Published: Sun. October 16, 2022 at 1:25 PM
Last updated: Sun. Oct 2022, 13: 31
The UAE’s Ministry of Health and Prevention on Sunday reported 322 cases of Covid-19 coronavirus, including 293 recoveries and no deaths.
Most COVID-19 patients who have persistent symptoms at 12 months are more likely to have symptoms at 18 months, according to new data.
The findings come from a giant study of another 33,281 people in Scotland who tested positive for coronavirus. Most effects are similar to those of previous, smaller studies.
Among a subset of 197 survivors of symptomatic SARS-CoV-2 infections who responded to surveys at 12 and 18 months, the maximum number of persistent symptoms reported at either time point, the researchers reported in Nature Communications.
Meanwhile, Pfizer Inc and its German partner BioNTech said Thursday that their Omicron-adapted Covid-19 vaccine booster generated an immune reaction opposite to Omicron’s BA. 5 and BA. 4 subvariants circulating lately.
The companies said data from a trial in adult patients showed that the booster dose resulted in a very extensive accumulation of neutralizing antibody levels compared to the BA. 4/BA. 5 variants.
Traditional Omicron shots through Pfizer and Moderna Inc. they have already been illuminated in several countries, adding in the U. S. In the U. S. for adults and, more recently, for children up to age five.
READ ALSO: